Innovative study unveils rare liver disease secrets
Study offers new insights into the role of macrophages
Medicine by Design invests $1 million in Convergent Working Group projects to integrate new strands of inquiry and expand its community across sectors
Seven new projects will focus on equity, commercialization policy, new regenerative medicine applications and more
Mini-symposium brings together researchers focused on developing type 1 diabetes therapies that can evade the immune system
Event was part of a series that explores convergent approaches in Medicine by Design’s team projects
Medicine by Design launches funding for Convergent Working Groups to take strategic action in regenerative medicine
Convergent Working Groups aim to bring wide-ranging expertise and perspectives together
Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.
Program selects inaugural incubator companies
New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours
Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.
Medicine by Design-funded researchers develop a new tool for scooping contents of individual cells from their local environment
Scientists can now select individual cells from their local environment & study their molecular contents. The new tool will enable a deeper study of stem cells and other rare cell types for diagnostics & therapy.
Seven funded projects poised to impact many diseases including cystic fibrosis, ALS and vision loss.
Research to impact cancer, Alzheimer’s disease, autism, aneurysm and more.
U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.
'We think we can really accelerate the field and its capacity to improve lives'
Medicine by Design to accelerate regenerative medicine discovery and translation with new $20-million investment
Projects to advance stem cell and gene therapy, enhance understanding of how the body repairs itself, and generate new technologies that will propel the field for decades